Series A · Medtech & Devices · Espoo, Finland · Founded 2017 · 10–15 employees
Surgify Medical has developed the innovative Surgify Halo technology, a tissue-selective bone surgery device that protects soft tissues during bone cutting procedures and prevents potentially life-threatening complications like nerve damage and bleeding. The company recently raised €7 million in Series A funding led by ZEISS Ventures and has already used its technology in over 1,000 patient procedures. With regulatory approvals in both the EU and US, Surgify is expanding internationally and has demonstrated significant traction in the multi-billion-euro bone surgery device market. The technology offers revolutionary safety features for surgeries involving the head, neck, and spine, and shows promise for robotic surgery applications.
No open roles listed right now.